Newly discovered species of bacteria in the microbiome may be a culprit behind rheumatoid arthritis
A new species of bacteria that doesn’t normally live in the gut may trigger an immune response so strong that it spreads to the joints.
The conversation
Louis Pasteur’s scientific discoveries in the 19th century revolutionized medicine and continue to save the lives of millions today
On World Rabies Day – which is also the anniversary of French microbiologist Louis Pasteur’s death – a virologist reflects on the achievements of this visionary scientist.
HIV therapies currently need to be taken regularly for life – longer-lasting antibody treatments could one day offer an equally effective one-shot alternative
Antiretroviral therapies for HIV, while extremely effective, need to be taken daily for life. Designing antibody treatments that need to be taken only once could improve compliance and reduce drug resistance.
I’ve had COVID and am constantly getting colds. Did COVID harm my immune system? Am I now at risk of other infectious diseases?
Evidence is growing there are changes to your immune system that may put you at risk of other infectious diseases.
Long COVID: How researchers are zeroing in on the self-targeted immune attacks that may lurk behind it
A new study finds that misdirected immune responses can persist for months in those who are suffering from long COVID-19.
When COVID-19 or flu viruses kill, they often have an accomplice – bacterial infections
Coinfections with bacteria can make viral infections even deadlier. Researchers have identified a protein in immune cells that may play a role in fighting both types of pathogens.
Long COVID-19 and other chronic respiratory conditions after viral infections may stem from an overactive immune response in the lungs
While a strong immune response is essential to fight against viral infection, an immune system that continues to stay active long after the virus has been cleared can lead to lung damage.
Future COVID-19 booster shots will likely need fresh formulations as new coronavirus variants of concern continue to emerge
A new generation of vaccines and boosters against SARS-CoV-2 may take a page from the anti-influenza playbook, with shots periodically tailored to target the most commonly circulating virus strains.